Searchable abstracts of presentations at key conferences in endocrinology

ea0092ps1-03-03 | Miscellaneous 1 | ETA2023

Treatment of obesity with thyroid hormones: data from the thesis* collaboration. *treatment of hypothyroidism in europe by specialists, an international survey

Carlos Galofre Juan , Jose Diez Juan , Attanasio Roberto , Nagy Endre , Negro Roberto , Papini Enrico , Perros Petros , Zarkovic Milos , Hegedus Laszlo

Objectives: The use of thyroid hormones (TH) to treat obesity is not supported by evidence based on efficacy and safety, and this is reflected in recommendations of major international guidelines on hypothyroidism and obesity. We aimed to explore views about this practice among European thyroid specialists and their associations with respondent characteristics.Methods: Thyroid specialists from 28 countries were invited to participate in a questionnaire s...

ea0092ps3-21-01 | Hypothyroidism | ETA2023

Patients’ persistent symptoms during therapy for hypothyroidism: results from the "thesis"* collaboration. (*treatment of hypothyroidism in europe by specialists, an international survey)

Attanasio Roberto , Zarkovic Milos , Hegedus Laszlo , Nagy Endre V. , Negro Roberto , Perros Petros , Papini Enrico , on behalf of the THESIS collaborators group

Background: Levothyroxine (LT4) is considered the standard of care for hypothyroidism, however 5-10% of hypothyroid individuals complain of persistent symptoms despite achieving biochemical euthyroidism on LT4.Methods: 17,247 thyroid specialists from 28 countries were invited to participate in a survey. It enquired about respondents’ perceptions of the cause of hypothyroid-like persistent symptoms and how the prevalence of such complaints had change...

ea0092ps3-21-02 | Hypothyroidism | ETA2023

Use of t3-containing treatments for hypothyroidism: results from the "thesis"* collaboration (*treatment of hypothyroidism in europe by specialists: an international survey)

Papini Enrico , Attanasio Roberto , Zarkovic Milos , Hegedus Laszlo , Nagy Endre V. , Negro Roberto , Perros Petros , behalf of the THESIS collaborators group on

Background: Levothyroxine (LT4) monotherapy is the mainstay of treatment of hypothyroidism, but a sizeable minority of endocrinologists also use T3-containing treatments in some patients notwithstanding concern about their safety.Methods: 17,247 thyroidologists from 28 countries were invited to participate in a questionnaire survey. Geographic regions were defined according to the UN Statistics Division. Gross national income (GNI) information stems from...

ea0099ep408 | Adrenal and Cardiovascular Endocrinology | ECE2024

Pseudo cushing syndrome with gastrointestinal sarcoidosis: case report

Al Hadad Hemmet , Fayed Ahmed , Sameh Ihab , Nagy Mohamed , Hamdy Sheriff , El Makzangy Hesham , Hamdy Reem , makram mirette , Salam Randa

Introduction: Pseudo Cushing syndrome (PCS) is caused by non-neoplastic over activity of the hypothalamic-pituitary-adrenal axis. Differentiating between PCS and Cushing disease (CD) can be challenging because of their overlapping clinical and biochemical features.Case presentation: 15 year old male presenting with watery diarrhea of 2 months duration occurring 3 times per day with lower limb weakness No rectal bleeding, fever, or weight loss<p class...

ea0099ep878 | Thyroid | ECE2024

Challenging thyroid storm in pregnancy case report

El Haddad Hemmat , Murad Heba , Hamdy Nehal , Abdel Aziz Rokaya , Moustafa Heba , Salam Randa , Magdy Mohamed , Nagy Fady , Atef Ahmed

Introduction: Thyroid storm is a rare complication of hyperthyroidism. In pregnant patients can cause spontaneous abortions, fetal demise. Aggressive treatment is needed.Case report: 26 years female 20 weeks pregnant; Graves’ disease for five years, was on carbimazole but she discontinued since she became pregnant Shortly after that, she started to complain with progressive dyspnea at less than ordinary effort, bilateral lower limb swelling, increas...

ea0081ep400 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Association of chemerin and serum advanced glycation end products in patients with autoimmune thyroiditis

Bak-Csiha Sara , Halmi Sandor , Hutkai David , Molnar Istvan , Katko Monika , Lőrincz Hajnalka , Harangi Mariann , Paragh Gyorgy , Nagy Endre , Bodor Miklos , Eszter Berta

Background: Hypothyroidism due to autoimmune thyroiditis leads to atherogenic lipid profile and metabolic changes. The formation of advanced glycation end products (AGEs) increases with hyperglycemia, hyperlipidemia and oxidative stress. Degradation of AGEs after AGEs-receptor 1-mediated intracellular uptake and renal clearance of soluble AGEs generated by certain cells like macrophages play a crucial role in the decrement of circulating AGEs level. Chemerin is an adipokine pr...

ea0084ps2-06-54 | Hypothyroidism Treatment | ETA2022

Treatment of hypothyroidism in europe by specialists: an international survey (THESIS): analysis of contested indications for prescribing among uk participants

R Younes Younes , Perros Petros , Hegedus Laszlo , Papini Enrico , V Nagy Endre , Attanasio (ORCID: 0000-0002-1417-287X) Roberto , Negro Roberto , C.T. Field (ORCID: 0000-0002-1883-1588) Benjamin

Objectives: We present findings from the UK arm of the THESIS collaboration, a pan-European survey of endocrinologists’ opinions and current practice in the management of hypothyroid and euthyroid disorders.Methods: UK clinical members of the Society of Endocrinology and the British Thyroid Association were invited to participate in an online survey.Results: 272 of 1295 (21%) eligible members completed the survey. More than 50...

ea0090p241 | Thyroid | ECE2023

Investigations on fibroblast growth factor 21 and lipid parameters in patients with Hashimoto thyroiditis

Bak-Csiha Sara , Hutkai David , Lőrincz Hajnalka , Harangi Mariann , Bodor Miklos , Katko Monika , Nagy Endre , Paragh Gyorgy , Eszter Berta

Background: Fibroblast growth factor 21 (FGF21) is a hormonal regulator of lipid and glucose metabolism exerting protection against atherosclerosis by multiple actions on the blood vessels, liver, and adipose tissues. Enhanced FGF21 production in diabetes and obesity reduces the level of LDL-C and triglycerides by suppression of hepatic SREBP-2. Hypothyroidism has also been shown to have unfavorable effects on atherogenesis and dyslipidemia. To date, the association of lipid p...

ea0049gp3 | Adrenal 1 | ECE2017

Exosomal hsa-miR-483-5p and hsa-miR-101 are potential minimally invasive biomarkers of adrenocortical carcinoma

Perge Pal , Butz Henriett , Pezzani Raffaele , Bancos Irina , Nagy Zoltan , Decmann Abel , Luconi Michaela , Mannelli Massimo , Buzas Edit Iren , Toth Miklos , Boscaro Marco , Patocs Attila , Igaz Peter

Background: Extracellular vesicles (exosomes, microvesicles) shed from tumor cells containing microRNAs can be exploited as markers of malignancy. The preoperative diagnosis of adrenocortical malignancy is difficult and microRNAs have proved useful in the diagnosis of many tumors, including adrenocortical cancer (ACC), but there have no studies to date on extracellular vesicle associated microRNAs in ACC.Aim: To evaluate the diagnostic potential of extra...

ea0037ep853 | Thyroid cancer | ECE2015

Detection of somatic oncogene alterations in FNA samples of cold nodules and 3 years follow-up of patients in Hungary

Tobias Balint , Balla Bernadett , Kosa P Janos , Takacs Istvan , Nagy Zsolt , Horvath Peter , Jaray Balazs , Szekely Eszter , Istok Roland , Szekely Tamas , Lakatos Peter

Cold nodules are one of the most common findings on scintigraphic examinations of the thyroid gland. About 5–10% of these nodules turn out to be histologically malignant. Our aim was to examine some somatogenetic alterations associated with thyroid cancer in FNA samples of the thyroid. These alterations included single nucleotide mutations (BRAF, HRAS, NRAS, KRAS) and genetic translocations (RET/PTC1, RET/PTC3, PAX8ex7/PPARgamma, PAX8ex9/PPARgamma). The SNPs were tested b...